James Wilson, M.D., Ph.D., on Gene Therapy as a Disruptive Technology

Dr. James Wilson is a professor in the department of pathology and laboratory medicine, and the director of the gene therapy program, at the University of Pennsylvania. He is also the editor of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc. During this interview with GEN, Dr. Wilson discusses his concept of a disruptive technology and explains why he believes gene therapy falls into this category.
In addition to this SKYPE interview, Dr. Wilson further elaborated on his view of gene therapy as a disruptive technology in a column in the January 2012 issue of Human Gene Therapy which can be viewed here: http://online.liebertpub.com/doi/pdfplus/10.1089/hum.2011.2530

Category:

Science & Technology

Tags:

• gene therapeutics
• university of Pennsylvania
• GEN News
• genetic engineering
• genetics
• genetic medicine
• genetic mutations